These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 23826864)

  • 21. Sweroside attenuates podocyte injury and proteinuria in part by activating Akt/BAD signaling in mice.
    Huang M; Yang Y; Chen Y; Li Y; Qin S; Xiao L; Long X; Hu K; Li Y; Ying H; Ding Y
    J Cell Biochem; 2023 Nov; 124(11):1749-1763. PubMed ID: 37796169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Klotho ameliorates diabetic nephropathy by activating Nrf2 signaling pathway in podocytes.
    Xing L; Guo H; Meng S; Zhu B; Fang J; Huang J; Chen J; Wang Y; Wang L; Yao X; Wang H
    Biochem Biophys Res Commun; 2021 Jan; 534():450-456. PubMed ID: 33256980
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A plasminogen activator inhibitor type 1 mutant retards diabetic nephropathy in db/db mice by protecting podocytes.
    Zhang J; Gu C; Lawrence DA; Cheung AK; Huang Y
    Exp Physiol; 2014 May; 99(5):802-15. PubMed ID: 24443353
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Olmesartan Prevents Microalbuminuria in db/db Diabetic Mice Through Inhibition of Angiotensin II/p38/SIRT1-Induced Podocyte Apoptosis.
    Gu J; Yang M; Qi N; Mei S; Chen J; Song S; Jing Y; Chen M; He L; Sun L; Hu H; Li L; Wüthrich RP; Wu M; Mei C
    Kidney Blood Press Res; 2016; 41(6):848-864. PubMed ID: 27871084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MiR-30 family prevents uPAR-ITGB3 signaling activation through calcineurin-NFATC pathway to protect podocytes.
    Lang Y; Zhao Y; Zheng C; Lu Y; Wu J; Zhu X; Zhang M; Yang F; Xu X; Shi S; Liu Z
    Cell Death Dis; 2019 May; 10(6):401. PubMed ID: 31127093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Salvianolate ameliorates oxidative stress and podocyte injury through modulation of NOX4 activity in db/db mice.
    Liang Y; Liu H; Fang Y; Lin P; Lu Z; Zhang P; Jiao X; Teng J; Ding X; Dai Y
    J Cell Mol Med; 2021 Jan; 25(2):1012-1023. PubMed ID: 33332718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vitamin D Ameliorates Podocyte Injury by Enhancing Autophagy Activity in Diabetic Kidney Disease.
    Zhang X; Zhang L; Wen Y; Zhang M; Liu S; Xiao H
    Kidney Blood Press Res; 2023; 48(1):314-325. PubMed ID: 37054686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FK506 ameliorates podocyte injury in type 2 diabetic nephropathy by down-regulating TRPC6 and NFAT expression.
    Ma R; Liu L; Jiang W; Yu Y; Song H
    Int J Clin Exp Pathol; 2015; 8(11):14063-74. PubMed ID: 26823720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Silencing of Histone Deacetylase 9 Expression in Podocytes Attenuates Kidney Injury in Diabetic Nephropathy.
    Liu F; Zong M; Wen X; Li X; Wang J; Wang Y; Jiang W; Li X; Guo Z; Qi H
    Sci Rep; 2016 Sep; 6():33676. PubMed ID: 27633396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protein S Protects against Podocyte Injury in Diabetic Nephropathy.
    Zhong F; Chen H; Xie Y; Azeloglu EU; Wei C; Zhang W; Li Z; Chuang PY; Jim B; Li H; Elmastour F; Riyad JM; Weber T; Chen H; Wang Y; Zhang A; Jia W; Lee K; He JC
    J Am Soc Nephrol; 2018 May; 29(5):1397-1410. PubMed ID: 29511111
    [No Abstract]   [Full Text] [Related]  

  • 31. Podocyte EGFR Inhibits Autophagy Through Upregulation of Rubicon in Type 2 Diabetic Nephropathy.
    Li Y; Pan Y; Cao S; Sasaki K; Wang Y; Niu A; Fan X; Wang S; Zhang MZ; Harris RC
    Diabetes; 2021 Feb; 70(2):562-576. PubMed ID: 33239448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of GPR120 in podocytes ameliorates kidney fibrosis and inflammation in diabetic nephropathy.
    Wei TT; Yang LT; Guo F; Tao SB; Cheng L; Huang RS; Ma L; Fu P
    Acta Pharmacol Sin; 2021 Feb; 42(2):252-263. PubMed ID: 32948825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy.
    Jha JC; Thallas-Bonke V; Banal C; Gray SP; Chow BS; Ramm G; Quaggin SE; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
    Diabetologia; 2016 Feb; 59(2):379-89. PubMed ID: 26508318
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Erythropoietin ameliorates podocyte injury in advanced diabetic nephropathy in the db/db mouse.
    Loeffler I; Rüster C; Franke S; Liebisch M; Wolf G
    Am J Physiol Renal Physiol; 2013 Sep; 305(6):F911-8. PubMed ID: 23825071
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inflammatory stress exacerbates lipid accumulation and podocyte injuries in diabetic nephropathy.
    Zhang Y; Ma KL; Liu J; Wu Y; Hu ZB; Liu L; Lu J; Zhang XL; Liu BC
    Acta Diabetol; 2015 Dec; 52(6):1045-56. PubMed ID: 25896009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Valsartan slows the progression of diabetic nephropathy in db/db mice via a reduction in podocyte injury, and renal oxidative stress and inflammation.
    Zhou G; Cheung AK; Liu X; Huang Y
    Clin Sci (Lond); 2014 May; 126(10):707-20. PubMed ID: 24195695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of p53/miR-34a/SIRT1 axis ameliorates podocyte injury in diabetic nephropathy.
    Liang Y; Liu H; Zhu J; Song N; Lu Z; Fang Y; Teng J; Dai Y; Ding X
    Biochem Biophys Res Commun; 2021 Jun; 559():48-55. PubMed ID: 33932899
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An adjustment in BMP4 function represents a treatment for diabetic nephropathy and podocyte injury.
    Fujita Y; Tominaga T; Abe H; Kangawa Y; Fukushima N; Ueda O; Jishage KI; Kishi S; Murakami T; Saga Y; Kanwar YS; Nagai K; Doi T
    Sci Rep; 2018 Aug; 8(1):13011. PubMed ID: 30158674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genipin inhibits mitochondrial uncoupling protein 2 expression and ameliorates podocyte injury in diabetic mice.
    Qiu W; Zhou Y; Jiang L; Fang L; Chen L; Su W; Tan R; Zhang CY; Han X; Yang J
    PLoS One; 2012; 7(7):e41391. PubMed ID: 22848482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dopamine 1 receptor activation protects mouse diabetic podocytes injury via regulating the PKA/NOX-5/p38 MAPK axis.
    Shao X; Zhang X; Hu J; Gao T; Chen J; Xu C; Wei C
    Exp Cell Res; 2020 Mar; 388(2):111849. PubMed ID: 31954110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.